Abstract:Objective To determine the morbidity of cervical intraepithelial neoplasia 2+(CIN2+) and CIN3+of different human papillomavirus(HPV)subtype infection combined with different cytology status.Methods The Shenzhen Cervical Cancer Screening Trial Ⅰ & Ⅱ(SHENCCASTⅠ&Ⅱ)are population-based cross-sectional cervical cancer screening studis conducted in Shenzhen and surrounding area from 2008 to2010.A total of 12 097 women who aged 25-59 years were included in the analysis.All of these women were detected by liquid-based cytology test and several high-risk HPV-DNA tests.The ones with HPV positive or atypical squamous cells of undetermined sign(ASC-US)were sequentially conducted by cervical biopsy vaginoscopy.Finally,10 805 samples with complete data of hybrid capture 2(HC2),the polymerase chain reaction-based matrix-assisted laser desorption/ionization time-of-flight assay(MALDI-TOF), HPV genotyping detection,cytology and pathology results were analyzed.Results The top 6 infection rates of HR-HPV in CIN2+and CIN3+were HPV16, HPV52, HPV58, HPV33, HPV31, HPV18.The highest constituent ratio of cytology in CIN 2+and CIN3+was high grade squamous intraepithelial lesion(HSIL).The morbidities of CIN2+of patients infected with HPV16, HPV31, HPV58, HPV33, HPV18, HPV52 were 41.3%, 31.5%, 30.6%, 28.7%, 28.2%, 17.7 %, respectively, while the morbidities of CIN3+of those were 33.5 %,20.5%, 19.4%, 15.7%, 19.2%,8.3%, respectively.The morbidities of CIN2+in negative intraepithelial lesion or malignancy(NILM),ASC-US, low grade squamous intraepithelial lesion(LSIL), atypical squamous cell cannot exclude high-grade squamous intraepithelial lesion(ASC-H), high grade squamous intraepithelial lesion(HSIL), atypical glandular cell(AGC)samples were 0.4%, 6.9%, 11.1%,36.4%,82.0%,16.7%,respectively,while the morbidities of CIN3+of those were 0.2%,3.1%, 4.2%,22.7%, 64.8%, 0.0%, respectively.The morbidities of CIN2+in NILM combined with HPV16, HPV18,HPV31, HPV33 infection were 12.6%, 13.3%, 15.8% and 11.5%, respectively, while the morbidities of CIN3+of those were 10.3%,11.1%,7.9%and 7.7%,respectively.The morbidities of CIN2+and CIN3+in ASC-US combining with hrHPV infection were high, and the top 6 subtypes associated with high risk of CIN2+were HPV31(35.7%), HPV33(26.9%), HPV16(26.5%), HPV58(22.4%), HPV52(18.6%), HPV68(15.4%), while those associated with high risk of CIN 3+were HPV16 (20.4%),HPV31(14.3%),HPV33(11.5%), HPV58(8.6%), HPV68(7.7%), HPV52(5.8%). Conclusions Cytology combined with HPV genotyping detection can more effectively estimate the morbidity risks of CIN2+and CIN3+.Both high prevalence rates and high risks associated with CIN 2+and CIN3+of HPV31,HPV33,HPV52 and HPV58 are observed.NILM and ASC-US status combined with these subtypes mentioned above are advised to be conducted by colposcopy.

Extended Human Papillomavirus Genotype Distribution and Cervical Cytology Results in a Large Cohort of Chinese Women with Invasive Cervical Cancers and High-Grade Squamous Intraepithelial Lesions.

Clinical Significance of Genotyping for Human Papillomavirus (HPV) 16 18/45 Combined with Cytology in Cervical Exfoliated Cells in HPV Oncogenic Mrna-Positive Women

Extended Human Papilloma Virus Genotyping for Risk Assessment of Cervical Intraepithelial Neoplasia Grade 2 or Worse in a Cohort Study

Extended human papillomavirus genotype distribution in cervical intraepithelial neoplasia and cancer: Analysis of 40 352 cases from a large academic gynecologic center in China

Prevalence of High-Risk Human Papillomavirus and Cervical Lesion Risk Factors: A Population-Based Study in Zhejiang, China 2010-2019

Extended HPV Genotyping for Risk Assessment of Cervical Intraepithelial Neoplasia Grade 2/3 or Worse in a Cohort Study

Prevalence Characteristics of High-Risk Human Papillomaviruses in Women Living in Shanghai with Cervical Precancerous Lesions and Cancer

High-Risk Genotypes of Human Papillomavirus at Diverse Anogenital Sites among Chinese Women: Infection Features and Potential Correlation with Cervical Intraepithelial Neoplasia

Distribution of Human Papillomavirus Genotypes in the Patients with Cervical Carcinoma and Its Precursors in Zhejiang Province, China

Prevalence of HPV-16/18 genotypes and immediate histopathologic correlation results in a Chinese population with negative cytology and positive high-risk HPV testing.

Prevalence and Carcinogenic Risk of High-Risk Human Papillomavirus Subtypes in Different Cervical Cytology: a Study of 124,251 Cases from the Largest Academic Center in China.

Risk stratification for cervical neoplasia using extended high-risk HPV genotyping in women with ASC-US cytology: A large retrospective study from China

Atypical Squamous Cells of Undetermined Significance Cervical Cytology in the Chinese Population: Age‐stratified Reporting Rates, High‐risk HPV Testing, and Immediate Histologic Correlation Results

HPV genotyping of cervical histologic specimens of 61, 422 patients from the largest women hospital in China

The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases

Prevalence And Genotype Distribution Of Human Papillomavirus In Women With Cervical Cancer Or High-Grade Precancerous Lesions In Chengdu, Western China

Evaluation of CIN2+/CIN3+risk of Different HPV Subtypes Infection Combined with Abnormal Cytology Status

Genotype profile of HPV in ASC-H cytology and histologic follow-up-prevalence, distribution, and risk: A retrospective study of 1414 cases

Diagnostic value of high-risk HPV other than type 16/18 in high-grade cervical neoplasia among cytology-negative women: A multicenter retrospective study

Human papillomavirus infections among women with cervical lesions and cervical cancer in Eastern China: genotype-specific prevalence and attribution

Association of human papillomavirus genotype distribution and cervical cytology: a cross-sectional study